96730 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links Cyclic peptides with only normal peptide bonds in the ring
Sub-classes:POLYMORPHIC FORMS OF CYCLO (-HIS-PRO) AND METHODS OF USE TO TREAT KIDNEY DISEASE
#2CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PRODUCING SAME, AND COMPOSITION
#3TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#4Peptide-Based Drugs for I.N. Delivery to Brain
#5SYRBACTIN MACROLACTAMS AND UNNATURAL ANALOGS AS PROTEASOME INHIBITORS FOR THE TREATMENT OF MULTIPLE MYELOMA AND CHEMOENZYMATIC SYNTHESIS THEREOF
#6SULPHONYL BENZENE DERIVATIVES AND METHODS FOR THE PREPARATION OF SULPHONYL BENZENE DERIVATIVES
#7METHOD OF GENERATING PULCHERRIMIN AND PULCHERRIMINIC ACID AND USES THEREOF
#8Cyclopeptide Glass and Pharmaceutical Composition Glass Containing Cyclopeptide
#9SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME
#10Cyclic peptide combinatorial libraries
#11TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#12PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
#13POLYMORPHIC FORMS OF CYCLO (-HIS-PRO) AND METHODS OF USE TO TREAT KIDNEY DISEASE
#14CYCLIC PEPTIDES AND CYCLIC PEPTIDE CONJUGATES FOR TREATING NEUROLOGICAL DISORDERS
#15Methods of identifying opioid cyclic peptides
#16CHIP SURFACE LINKER AND PREPARATION METHOD AND USE THEREFOR
#17COMPOSITIONS AND METHODS FOR BIOORTHOGONAL SURFACE COATING
#18Cyclopeptide and method for preparing the same
#19METHODS FOR TREATMENT OF CANCER COMPRISING TIGIT-BINDING AGENTS
#20Cell-protecting composition containing cyclo histidine-proline as active ingredient
#21PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
#22EPITOPES IN THE RNA RECOGNITION MOTIF 1 (RRM1) OF TDP-43 AND MISFOLDING-SELECTIVE ANTIBODIES THERETO
#23CYCLIC TETRAPEPTIDE STEREOISOMERS
#24Cyclic RGD peptide and method for preparing the same
#25PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
#26Rapaglutins, novel inhibitors of GLUT and use thereof
#27Composition for cell protection containing cyclo histidine-proline as active ingredient
#28Multifunction cyclic peptide polymer nanomaterials
#29Methods for treatment of cancer comprising TIGIT-binding agents
#30Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease
#31PEPTIDE COMPOSITIONS AND RELATED METHODS
#32Mertansine polypeptide conjugates
#33PEPTIDE COMPOSITIONS AND RELATED METHODS
#34USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
#35Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
#36Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies thereto
#37Peptide-Based Quorum Sensing Inhibitors for the Attenuation of Virulence in Staphylococcus Aureus
#38ANTIFIBRINOLYTIC COMPOUNDS
#39Cyclic peptides, cyclic peptide conjugates and methods of use thereof
#40Composition for cell protection containing cyclo histidine-proline as active ingredient
#41Methods for treatment of cancer comprising TIGIT-binding agents
#42Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment
#43Cyclic tetrapeptide stereoisomers
#44PEPTIDE COMPOSITIONS AND RELATED METHODS
#45EPHA4 cyclic peptide antagonists for neuroprotection and neural repair
#46USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
#47SIMPLIFIED AND SCALABLE METHOD FOR SYNTHESIS OF 2,6-BIS(METHIONYL)- 1,4-DIKETOPIPERAZINE
#48Use of CD36 to identify cancer subjects for treatment
#49Antifibrinolytic compounds
#50FAST DISSOLVING PHARMACEUTICAL COMPOSITION
#51Peptide compounds for inhibitions of platelet aggregation
#52Cyclic tetrapeptide stereoisomers
#53Method for inhibiting ADAM proteases with cyclic peptides
#54NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF
#55Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment
#56Cyclic amino acid molecules and methods of preparing the same
#57Cyclic peptides as ADAM protease inhibitors
#58Uric acid-lowering agent
#59Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides
#60Beta-turn peptidomimetic cyclic compounds for treating dry eye
#614-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#62Use of CD36 to identify cancer subjects for treatment
#63NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF
#64Combinations with a backbone-cyclized peptide
#65Fast dissolving pharmaceutical composition
#66Chemically labile peptide-presenting surfaces for cellular self-assembly
#674-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#68Beta-turn peptidomimetic cyclic compounds for treating dry eye
#69Peptide-based quorum sensing inhibitors for the attenuation of virulence in
#70Phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition
#714-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION
#72Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
#73Methods for preparing internally constrained peptides and peptidomimetics
#74Polyheterocyclic compounds highly potent as HCV inhibitors
#75Methods for Preparing Internally Constrained Peptides and Peptidomimetics
#76β-turn peptidomimetic cyclic compounds for treating dry eye
#77Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives
#78Cyclic amino acid molecules and methods of preparing the same
#79Cyclic peptides with an anti-parasitic activity
#80Polyheterocyclic compounds highly potent as HCV inhibitors
#81Beta-turn peptidomimetic cyclic compounds for treating dry eye
#82Macrocyclic peptides as inhibitors of viral replication
#83PROTEASE INHIBITION
#84Methods for preparing internally constrained peptides and peptidomimetics
#854-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
#86Process for the Manufacture of Eptifibatide
#87HCV protease inhibitors and uses thereof
#88Cyclodipeptide Synthetases and Their Use for Synthesis of Cyclo(Leu-Leu) Cyclodipeptide
#89Methods and compositions related to cyclic peptide synthesis
#904-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#91Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs
#92Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
#93Process for Producing Dipeptides
#94Peptide conjugates
#95Methods for preparing internally constrained peptides and peptidomimetics
#96Cyclopeptide derivatives with anti-integrin activity
#97Methods for preparing internally constrained peptides and peptidomimetics